May function as part of a signaling pathway that acts to regulate the size of the body fat depot. An increase in the level of LEP may act directly or indirectly on the CNS to inhibit food intake and/or regulate energy expenditure as part of a homeostatic mechanism to maintain constancy of the adipose mass. Defects in LEP may be a cause of obesity (OBESITY). It is a condition characterized by an increase of body weight beyond the limitation of skeletal and physical requirements, as the result of excessive accumulation of body fat. Belongs to the leptin family. Note: This description may include information from UniProtKB.
Protein type: Hormone; Cell development/differentiation; Secreted, signal peptide; Secreted
Biological Process: adult feeding behavior; angiogenesis; intestinal absorption; leptin-mediated signaling pathway; lipid metabolic process; negative regulation of appetite; negative regulation of autophagy; negative regulation of glucose import; placenta development; positive regulation of developmental growth; positive regulation of JAK-STAT cascade; positive regulation of MAPKKK cascade; positive regulation of phosphoinositide 3-kinase cascade; positive regulation of protein kinase B signaling cascade; positive regulation of T cell proliferation; positive regulation of TOR signaling pathway; prostaglandin secretion; regulation of angiogenesis; regulation of bone remodeling; regulation of cell cycle; regulation of endothelial cell proliferation; regulation of natural killer cell activation; regulation of natural killer cell mediated cytotoxicity; regulation of natural killer cell proliferation; regulation of nitric-oxide synthase activity; response to insulin stimulus; sexual reproduction; T cell differentiation; tyrosine phosphorylation of STAT protein
LTP: The number of records in which this modification site was determined using site-specific methods. SS methods include amino acid sequencing, site-directed mutagenesis, modification site-specific antibodies, specific MS strategies, etc.